FDA PDUFA goal date of August 15, 2025, for TNX-102 SL for the management of fibromyalgia; if approved, TNX-102 SL would ...

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) announced the outcomes of its annual shareholder meeting held on Thursday, May 8, 2025. The meeting saw the approval of seven key proposals, with 46.7 ...

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) announced the outcomes of its annual shareholder meeting held on Thursday, May 8, 2025. The meeting saw the approval of seven key proposals ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Short interest is currently not available. Nasdaq provides information of company’s short interest and the average days it takes to cover them. Short interest and days to cover can be used to ...

This page features the latest news about the Tonix Pharma stock. Noble Capital slashes Tonix Pharma share target on future sales outlook On Thursday, Noble Capital revised its price target on ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Fremanezumab reduced migraine attacks and depression symptoms in migraine patients with major depressive disorder.

A replay of the conference call will be available from 3:00 pm Eastern Time on May 15, 2025, until 11:59 pm Eastern Time on ...

Biopharma company Jazz Pharmaceuticals (NASDAQ:JAZZ) fell short of the market’s revenue expectations in Q1 CY2025, with sales flat year on year at $897.8 million. On the other hand, the company ...

Cheng Xin / Getty Images Vertex Pharmaceuticals missed first-quarter profit and revenue forecasts as costs jumped. The biotech firm also posted a decline in sales outside the U.S. because of ...